Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 101 SEK 0.3% Market Closed
Market Cap: 9.8B SEK

Biogaia AB
Investor Relations

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

Show more
Loading
BIOG B
OMX Stockholm 30

Earnings Calls

2025 Q3
Feb 13, 2025
Show Transcript
Previous
Next
Strong Growth in Revenue Amid Margins Contraction; Future Outlook Positive
2025 Q3
Feb 13, 2025

In Q3, the company reported a revenue growth of 15%, with industrial segments growing by 23% driven by strong demand, particularly in distribution and machinery. Automotive surged by 10%, while aftermarket segments experienced an 18% increase. However, gross margins declined by 4.5% year-over-year, primarily due to rising traded product costs, though a recovery is anticipated in Q4. Management expects long-term margin improvement as localization increases, targeting a return to 14-15%. With ongoing infrastructure spending fueling growth, the outlook remains robust across segments, including wind and rail, which are expected to gain further momentum in the near future.

Show Full Analysis

Management

Mr. Peter Rothschild M.Sc. Econ., MBA
Founder & Chairman
No Bio Available
Ms. Theresa P. Agnew
CEO & President
No Bio Available
Mr. Alexander Kotsinas M.Sc. (Eng.).
Executive VP & CFO
No Bio Available
Ludvig Milesson
Chief Operating Officer
No Bio Available
Mr. Gianfranco Grompone
Chief Scientific Officer and VP of Research & Development
No Bio Available
Ms. Caroline Mofors
Chief Legal Officer
No Bio Available
Ms. Linda Hagglund
Vice President of Marketing
No Bio Available
Ms. Angelika Kjelldorff
Chief HR Officer
No Bio Available
Sebastian Heimfors
VP & Chief Commercial Officer
No Bio Available
Jonathan Gromark
Sustainability Manager
No Bio Available

Contacts

Address
STOCKHOLM
Stockholm
Kungsbroplan 3
Contacts
+46855529300.0
sv.biogaia.com